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In the past, the most common mechanisms of resistance to
quinolones for pathogenic bacteria were the genetic mu-
tations in chromosomal encoding DNA gyrase and/or topo-
isomerase IV,1,2 and changes in the expression of porin
proteins for efflux pumps such as qepA and oqxAB were also
common quinolone resistance mechanisms.3 Recently, a
new plasmid mediated quinolone efflux pump, qepA1, was
identified in three Escherichia coli isolates from Japan and
Belgium.4,5 The qepA1 gene was associated with the rmtB
gene, which conferred high level resistance to amino-
glycosides.6,7 In the course of study, we discovered a novelof a novel qepA3 variant in Enterobacter aerogenes, Journal of
1016/j.jmii.2016.01.001
by Elsevier Taiwan LLC. This is an open access article under the CC
).
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+ MODELqepA3 variant, three qepA1, and one qepA2 determinants
in an isolate of Enterobacter aerogenes and four isolates of
E. coli, and reported features of the qepA genes.
Materials and methods
Strains
Ninety-eight consecutive non-duplicate isolates including E.
coli (43 isolates), E. aerogenes (36 isolates), and Enter-
obacter cloacae (19 isolates) were collected and detected
for qepA from specimens in our laboratories between
January 2008 and June 2010. Five of 98 isolates carried the
qepA gene by polymerase chain reaction (PCR) amplification
and sequencing. The numbers EC2468, EC2751, EC3762,
EC3319, and EA3201 represented these four isolates of E. coli
and one isolate of E. aerogenes, respectively. All isolates
were identified with Vitek GNIþ cards (bioMe´rieux, Lyon,
France), and species identification was confirmed by
sequence analysis of the16 S-23 S rRNA gene intergenic
spacer region.
Conjugation experiments
Conjugation experiments were performed with five isolates
as donors and azide-resistant E. coli J53 as recipient strain
by filter mating. Transconjugants were selected on LB agar
plates supplemented with sodium azide (150 mg/mL) and
ciprofloxacin (0.25 mg/mL). From the transconjugants,
plasmid DNA was extracted, and the DNA sequences adja-
cent to qepA were determined with primers, starting from
both sides of the qepA. The minimum inhibitory concen-
trations (MICs) for donors, transconjugants, and recipient
were also measured with MICs of quinolone and several b-
lactam antibiotics (Table 1).
PCR amplification, gene mapping, restriction with
HindIII, and southern hybridization of HindIII
digestion with qepA probe specific
To study the plasmids carrying qepA and surrounding genes
from five isolates, DNA was extracted from the plasmidsTable 1 Minimum inhibitory concentrations (MICs) of antimicrob
Antimicrobials Donors
EC2468/2751/3762/3319 EA3201
Ciprofloxacin 1/0.5/1/1 2
Levofloxacin 1/1/1/1 2
Ofloxacin 2/2/2/2 4
Nalidixic acid 64/32/64/64 64
Piperacillin 256/128/256/128 128
Cefazolin 256/128/256/256 256
Cefuroxime 128/64/32/32 32
Ceftazidime 2/4/2/1 2
Cefepime 1/0.5/0.25/0.5 0.05
Amikacin 2,048/4,096/1,024/2,048 2,048
EA-ECJ53, Escherichia coli transconjugant from isolates EA3201 and E
EC2751, EC3762, EC3319, and E. coli J53.
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gel electrophoresis (60 V, 90 minutes) (Promega, Madison,
USA). The gels were cut and plasmid DNA fragments of
different sizes were extracted. These plasmid DNA frag-
ments served as templates for PCR amplification of qepA
and surrounding genes, then sequencing, where the posi-
tions of these gene plasmids were determined. The size of
the plasmid DNAs was estimated.8 The amplified products
were also purified and digested with HindIII. The resulting
fragments were ligated into HindIII-digested plasmid
pBKCMV, and transformed into E. coli DH10B, which was
used for determining quinolone resistance genes. Mean-
while, the resulting fragments were electrophoresed
separately through 0.6% agarose gel, and were transferred
onto a positively charged nylon membrane (Boehringer,
Mannheim, Germany) with capillary transfer. Then, they
were subjected to southern hybridization of HindIII diges-
tion with qepA probe specific. The digoxigenin DNA labeling
and detection kits (Boehringer Mannheim) were utilized.Results
Susceptibility testing
The MICs of antimicrobial agents such as ciprofloxacin,
levofloxacin, ofloxacin, nalidixic acid, and others (Table 1)
were determined by the dilution methods according to the
Clinical and Laboratory Standards Institute guidelines. MIC
values of 83 isolates (39 E. coli, 29 E. aerogenes, and 15 E.
cloacae) showed ciprofloxacin  0.25 mg/mL, levofloxacin
 0.25 mg/mL, ofloxacin  0.5 mg/mL, and nalidixic acid 
16 mg/mL; MIC values of four isolates of E. coli (EC2468,
EC2751, EC3762, and EC3319) and one isolate of E. aero-
genes (EA3201) are listed in Table 1. The susceptibility
testing results showed that MICs of quinolones, several b-
lactam antibiotics, and amikacin for five isolates and the
transconjugants were generally much higher than those of
E. coli J53 (Table 1). Especially, MICs of the transconjugant
from isolate EA3201 (EA-ECJ53) at ciprofloxacin, levo-
floxacin, and ofloxacin are much higher than those of the
transconjugants from isolates EC2468, EC2751, EC3762, and
EC3319 (EC-ECJ53) (Table 1). Simultaneously, the ratios ofial agent for donors, transconjugants, and recipients (mg/mL).
Transconjugants Recipients
EC-ECJ53 EA-ECJ53 E.coliJ53
0.5/0.5/0.5/0.5 1 0.0125
0.5/0.5/0.25/1 1 0.0125
1/1/1/0.5 4 0.025
16/16/16/32 16 4
64/32/64/32 32 1
8/16/4/4 4 1
32/16/16/8 8 4
0.5/1/0.5/0.25 0.25 0.25
0.25/0.125/0.05/0.125 0.05 0.025
1,024/2,048/512/1,024 1,024 0.50
. coli J53; EC-ECJ53, E. coli transconjugant from isolates EC2468,
of a novel qepA3 variant in Enterobacter aerogenes, Journal of
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at ciprofloxacin, levofloxacin, and ofloxacin are also much
higher in 80-fold, 80-fold, and 160-fold levels, respectively.Genetic structure for qepA and surrounding genes
With PCR amplification and sequencing using primers, we
sequenced the plasmids of five isolates in lengths. The
qepA3 variant located on ca.102 kb-length plasmid EA3201,
and other qepAs located on ca.124 kb-, 145 kb-, 131 kb-,
and 111 kb-length plasmids from isolates EC2468, EC2751,
EC3762, and EC3319, respectively. By PCR amplification,
the recombinant plasmids were determined to have no
other quinolone resistant genes. Gene assembling and
analyzing showed that the qepA3, qepA1, and qepA2 de-
terminants from isolates EA3201, EC2468, EC2751, EC3762,
and EC3319 were flanked or linked by full- or partial-length
tnpA, intI1, rmtB, and blaTEM-1 genes (Figure 1); there were
five structures A, B, C, D, and E in these isolates.Figure 1. Partial genetic environments of the qepA3, qepA1, an
EC3762, and EC3319. The reading frames are shown as arrows wi
identified structures for the black arrows with opposite direction
minant). Restriction sites at aagctt with HindIII are indicated, pEA3
plasmids. (A) the genetic structure A harboring a novel qepA3 vari
respectively, harbouring qepA1 genes; (E) the genetic structure E
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aagctt are shown in Figure 1 and achieved recombinant
plasmids pEA3201, pEC2468, pEC2751, pEC3762, and
pEC3319 for ca. 6.2 kb-length plasmid fragments harboring
qepA and surrounding genes. Southern hybridization of
HindIII digestion with qepA probe specific indicated that
these qepAs also located on ca. 6.2 kb-length recombinant
plasmids.
Putative amino acid variations for qepA genes in
the isolates
Fourteen-transmembrane (TMS) motifs were analyzed.
Three mutations of amino acids in the QepA3 located on 8-,
10- and 12-TMS motifs, but two mutations were out of TMS
motifs. The putative amino acid point mutations might be
associated with the quinolone resistance in the isolates.
Five amino acid mutations were also observed for the novel
qepA3 variant from isolate EA3201, and they were differentd qepA2 determinants for plasmids EA3201, EC2468, EC2751,
th the arrowhead indicating the direction of transcription. It
representing qepA and tnpA genes (ISCR3C transposon deter-
201, pEC2468, pEC2751, pEC3762, and EC3319 are recombinant
ant gene; (B), (C), and (D), the genetic structure B, C, and D,
harboring qepA2 gene.
of a novel qepA3 variant in Enterobacter aerogenes, Journal of
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+ MODELat sites Ala (A) 235 Glu (E), Pro (P) 274 Leu (L), Trp (W) 318
Cys (C), Met (M) 372 Lys (K), and Ala (A) 445 Thr (T), when
compared with the qepA1 genes from isolates EC2468,
EC2751, and EC3762; the novel qepA3 variant gene was
deposited in GenBank as accession number JQ064560.
Promoter expression for blaTEM-1, rmtB and novel
qepA3 gene in genetic struction A
There are six genes in the 8663 bp PCR amplicon of genetic
structure A, including blaTEM-1, rmtB, intI1, novel qepA3,
and different-length tnpA genes. The sites of transcrip-
tional promoter for blaTEM-1, rmtB, and novel qepA3 genes
are indicated as þ1, also shown as 10 and 35 regions.
Discussion
This study determined the lower incidences (5/89) of qepA
gene among 89 nonrepetitive E. coli, E. aerogenes, and E.
cloacae of patient origins and characterized the positive
isolates. The presence of qepA genes was investigated, and
showed characteristics of qepA genes in the five isolates.
By analysis of susceptibility testing, the ratios of MICs for
the transconjugant from isolate EA3201 and recipient isolate
E. coli J53 at ciprofloxacin, levofloxacin, and ofloxacin were
highest in 80-fold, 80-fold, and 160-fold levels, respectively,
much higher than those for the transconjugants from isolates
EC2468, EC2751, EC3762, and EC3319 and recipient isolate E.
coli J53. The ratios were also far higher than those of a
reference report.8 We guessed it might be relevant to genetic
mutation, especially genetic mutation on 8-, 10- and 12-TMS
motifs. Therefore, we confirmed the novel qepA3 could in-
crease the MICs of quinolones at much higher levels; these
results also reminded us of the qepA dissemination mediating
with plasmids.
We determined a novel qepA variant from isolate EA3201
located on an approximately 102-kb-long plasmid, and
other qepAs located on approximately 124-kb-, 145-kb-,
131-kb-, and 111-kb-long plasmids from four other isolates.
These qepA genes were flanked or linked with full- or
partial-length tnpA, intI1, rmtB, and blaTEM-1 genes, and
five different genetic structures A, B, C, D, and E were
discovered in isolates EA2301, EC2468, EC2751, EC3762,
and EC3319, respectively, by gene mapping (Figure 1).
However, the common structures were identical with qepA
and tnpA genes (ISCR3C transposon determinants) showing
opposite direction in the five structures (Figure 1). Except
for the qepA1 from isolate EC2468 in structure B, the novel
qepA3 and the other qepA genes (qepA1 and qepA2 de-
terminants) were linked with rmtB genes as well in struc-
tures A, C, D, and E (Figure 1). The isolate EA3201 was first
isolated from a patient’s sputum in an intensive care unit
ward, and was subsequently discovered in the patient’s
blood as well. The patient was a farmer, and was once
wounded by a farm implement in the field before coming to
be hospitalized. We also determined the identific qepA3
variant from soil bacteria. The isolates EC2751, EC3762,
and EC3319 were also from farmers, but we had no evi-
dence to determine if the qepA genes came from soil or
poultry and livestock. The findings supported a hypothesisPlease cite this article in press as: Wang D, et al., Characterization
Microbiology, Immunology and Infection (2016), http://dx.doi.org/10.that the uptake of qepA from soil bacteria was by rmtB-
producing E. coli or E. aerogenes. Meanwhile, A qepA was
also found in an rmtB producing E. coli strain isolated in a
Belgian hospital, suggesting a probable worldwide dissem-
ination of qepA accompanied by rmtB, which had been
identified in Asia and Europe.9,10 Hence, active surveillance
of qepA-harboring Gram-negative bacteria in soil or animals
might reveal a greater prevalence of such kinds of
multidrug-resistant microbes.Conflicts of interest
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